Thai Technology Transfer Project

Ensure access to medicine in respective countries.

Thai Technology Transfers

Daiichi-Sankyo grants the right to a local subsidiary in China to produce and sell the combination products containing Olmesartan Medoxomil as one of its principal active ingredients.

Also, the company grants the right to contract manufacturing organizations in Thailand (Olic Ltd. and Inter Thai) to produce oral forms and IV of products containing extended dosage forms of Levofloxacin (new formulation project) and Tranexamic Acid. Daiichi Sankyo transferred intellectual property rights and technical know-how related to the manufacturing, testing, packaging, storage and holding of the active pharmaceutical ingredient and finished dosage form, including training their personnel from Daiichi Sankyo headquarters.


  • Daiichi Sankyo

    Service Providers
    Japan | Staff size: 10,000+

    Daiichi Sankyo is a global pharmaceutical company engaged in the research and development, manufacturing, and sale and marketing of innovative and generic drugs, vaccines, and over-the counter...

  • Interthai Pharmaceuticals

    Goods Supplier, Service Providers
    Thailand | Staff size: Unknown

    Research and Development

    They strive to ensure new high-quality and cost-effective product of various therapeutic and healthcare entities, while assisting...

  • OLIC Thailand

    Goods Supplier, Service Providers
    Thailand | Staff size: 26-50

    OLIC (Thailand) Limited is the largest provider of contract manufacturing services for pharmaceutical, healthcare, confectionary and supplement industries in Thailand and South-East Asia. OLIC...

More Resources

Key Information

LocationEast Asia and Pacific, China, Thailand
  • Start Date 2004